Loss	O
of	O
body	B-Organism_subdivision
weight	O
after	O
challenge	O
-	O
infection	O
with	O
WNV	O
.	O

Mice	O
(	O
n	O
=	O
8	O
)	O
were	O
vaccinated	O
intranasally	B-Immaterial_anatomical_entity
with	O
Flu	O
-	O
NA	O
-	O
DIII	O
(	O
*	O
)	O
or	O
Flu	O
-	O
NA	O
-	O
GFP	O
(	O
o	O
)	O
or	O
by	O
the	O
subcutaneous	B-Immaterial_anatomical_entity
route	O
(	O
^	O
and	O
^	O
,	O
respectively	O
)	O
.	O

The	O
daily	O
weights	O
of	O
each	O
animal	O
were	O
calculated	O
compared	O
to	O
their	O
respective	O
weight	O
on	O
the	O
day	O
of	O
challenge	O
,	O
and	O
data	O
are	O
shown	O
as	O
the	O
average	O
percentage	O
of	O
initial	O
weight	O
for	O
each	O
group	O
.	O

Error	O
bars	O
represent	O
the	O
standard	O
error	O
for	O
all	O
samples	O
available	O
at	O
that	O
time	O
point	O
.	O

Subsequently	O
,	O
the	O
mice	O
were	O
challenged	O
subcutaneously	B-Immaterial_anatomical_entity
with	O
106	O
TCID50	O
WNV	O
-	O
NY99	O
and	O
weighed	O
daily	O
.	O

The	O
mean	O
body	B-Organism_subdivision
weight	O
is	O
expressed	O
as	O
the	O
percentage	O
of	O
the	O
body	B-Organism_subdivision
weight	O
before	O
challenge	O
infection	O
(	O
A	O
)	O
.	O

The	O
survival	O
rates	O
of	O
mice	O
after	O
challenge	O
infection	O
with	O
WNV	O
-	O
NY99	O
are	O
depicted	O
as	O
Kaplan	O
-	O
Meier	O
survival	O
curves	O
(	O
B	O
)	O
.	O

The	O
difference	O
in	O
survival	O
rate	O
between	O
Flu	O
-	O
NA	O
-	O
DIII	O
and	O
Flu	O
-	O
NA	O
-	O
GFP	O
vaccinated	O
mice	O
was	O
statistically	O
significant	O
as	O
determined	O
by	O
the	O
logrank	O
test	O
.	O

The	O
symbols	O
for	O
the	O
respective	O
groups	O
are	O
the	O
same	O
as	O
in	O
panel	O
A	O
.	O

